Skip to main content
Fremanezumab benefits migraine patients with inadequate response to prior preventive medications
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Fremanezumab benefits migraine patients with inadequate response to prior preventive medications
User login
Username
Password
Reset your password
Concept
Lead
score
Migraine
1
1
Atherosclerosis
0
0.65
Vestibular System
0
0.65
Thyroid Disease
0
0.65
Inpatient Care
0
0.55
Thyroid
0
0.75
Hypothyroidism
0
0.75
Meta-Analysis
0
0.55
Refractory
0
0.28
Headache
0
0.65
Pain Management
0
0.75
Specialty
Lead
score
Neurology & Neurosurgery
1
1
Family Medicine/Primary Care
0
1
Internal Medicine
0
1
Pharmacist
0
0.33
Hospital Medicine
0
0.18
Edit Tags